PHESGO sol inj 600 mg/600 mg/10 ml flac
7680678280015
CH-67828
L01FY01
07.16.1.
Reimbursement limitations:
PHESGO.Adju
Traitement adjuvant du cancer du sein
PHESGO est remboursé en association avec une chimiothérapie dans …
1 / 3
google
Details
- Product number
- 6782801
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- pertuzumabum 600 mg, trastuzumabum 600 mg, hyaluronidasum humanum ADNr, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, saccharum, polysorbatum 20, dl-methioninum, aqua ad iniectabile q.s. ad solutionem pro 10 ml.
Articles (1)
Phesgo 600 mg/600 mg/10 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
600.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
600.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 3620.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2022
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 67828
- Drug name
- Phesgo, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01FY01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 08/04/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PHESGO sol inj 600 mg/600 mg/10 ml flac
- Description (DE)
- PHESGO Inj Lös 600 mg/600 mg/10 ml Durchstf
- Market launch
- 08/04/2021
- Narcotic (BTM)
- No